GCG and bone fracture: A meta-analysis in 2013 reported that different GLP1 analogs had opposite effects on the risk of osteoporotic fracture45, and a more recent meta-analysis concluded that only two GLP1 analogs, liraglutide and lixisenatide, reduced bone fracture risk and that their effect depended on the treatment duration24.